The use of HIV post-exposure prophylaxis in forensic medicine following incidents of sexual violence in Hamburg, Germany: a retrospective study

Forensic Sci Med Pathol. 2018 Sep;14(3):332-341. doi: 10.1007/s12024-018-9985-7. Epub 2018 May 18.

Abstract

In Hamburg, Germany, the initiation of HIV post-exposure prophylaxis (HIV PEP) in cases of sexual violence is often carried out by forensic medical specialists (FMS) using the city's unique Hamburg Model. FMS-provided three-day HIV PEP starter packs include a combination of raltegravir and emtricitabine/tenofovir. This study aimed to investigate the practice of offering HIV PEP, reasons for discontinuing treatment, patient compliance, and whether or not potential perpetrators were tested for HIV. We conducted a retrospective study of forensic clinical examinations carried out by the Hamburg Department of Legal Medicine following incidents of sexual violence from 2009 to 2016. One thousand two hundred eighteen incidents of sexual violence were reviewed. In 18% of these cases, HIV PEP was initially prescribed by the FMS. HIV PEP indication depended on the examination occurring within 24 h after the incident, no/unknown condom use, the occurrence of ejaculation, the presence of any injury, and the perpetrator being from population at high risk for HIV. Half of the HIV PEP recipients returned for a reevaluation of the HIV PEP indication by an infectious disease specialist, and just 16% completed the full month of treatment. Only 131 potential perpetrators were tested for HIV, with one found to be HIV positive. No HIV seroconversion was registered among the study sample. Provision of HIV PEP by an FMS after sexual assault ensures appropriate and prompt care for victims. However, patient compliance and completion rates are low. HIV testing of perpetrators must be carried out much more rigorously.

Keywords: Forensic medical examination; Forensic medical specialist; HIV; Post-exposure prophylaxis; Sexual assault; Sexual violence.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-HIV Agents / administration & dosage
  • Child
  • Child, Preschool
  • Emtricitabine / administration & dosage
  • Female
  • Germany / epidemiology
  • HIV Infections / prevention & control*
  • Humans
  • Male
  • Medication Adherence
  • Middle Aged
  • Post-Exposure Prophylaxis / statistics & numerical data*
  • Raltegravir Potassium / administration & dosage
  • Retrospective Studies
  • Sex Offenses / statistics & numerical data*
  • Tenofovir / administration & dosage
  • Young Adult

Substances

  • Anti-HIV Agents
  • Raltegravir Potassium
  • Tenofovir
  • Emtricitabine